Italians to vote in seven regions, referendum Expected centre-right successes could hurt government Referendum cutting number of lawmakers likely to pass ROME, Sept 9 (Reuters) - A raft of local ...

Researchers believe they have developed the first dedicated blood test to diagnose chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), which has the potential to be a ...

The Avantect Multi-Cancer Detection Test is a simple blood test designed to screen for several types of cancer simultaneously in asymptomatic, generally healthy persons. It targets some of the ...

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook DeepSeek has upgraded its model to V3.1-Terminus, enhancing language consistency by reducing mixed ...

Swiss-based Roche announced this month that it has received U.S. regulatory clearance for a less-complex vitamin D test in the United States, which the company said opens the door to more efficient ...

The iPhone 16 and 16e showed similar network speeds in most regions. The iPhone 16 outperformed the 16e on more advanced networks. The iPhone 17 is expected to continue to use Qualcomm modems. Looking ...

(RTTNews) - The first FDA-cleared blood test that aids in the diagnosis of Alzheimer's disease has been launched by Labcorp (LH), a global life sciences and healthcare company. The test, named ...

Arizona State University scientists have unveiled NasRED, a revolutionary one-drop blood test that can detect diseases like COVID-19, Ebola, HIV, and Lyme with incredible speed and precision. Using ...

Please provide your email address to receive an email when new articles are posted on . It is estimated that at least 12 million people in the United States are affected by diagnostic errors each year ...

The Alzheimer's Association released its first comprehensive clinical practice guidelines for the diagnosis, treatment, and care of Alzheimer's disease (AD) at the end of July. This landmark document ...

The FDA approved the Oncomine Dx Target Test for identifying HER2-mutant NSCLC patients eligible for Hernexeos, an oral tyrosine kinase inhibitor. Hernexeos offers a new treatment option for ...